Erschienen in:
01.04.2007
Reconstituted Botulinum Type A Neurotoxin: Clinical Efficacy After Long-Term Freezing Before Use
verfasst von:
Alan A. Parsa, M.D., Kevin D. Lye, M.D., Fereydoun Don Parsa, M.D., F.A.C.S.
Erschienen in:
Aesthetic Plastic Surgery
|
Ausgabe 2/2007
Einloggen, um Zugang zu erhalten
Abstract
Botulinum neurotoxin type A (BoNT/A) is injected into muscles of facial expression for treatment of facial wrinkles. Manufacturers’ recommendations state that the product should be used within 4 h of reconstitution to prevent loss of effectiveness. A prospective study was undertaken to evaluate the effectiveness of reconstituted BoNT/A when preserved in a frozen state for up to 6 months, as compared with nonfrozen BoNT/A used within 4 h after reconstitution. Treatment of 118 sites in 80 patients was performed and evaluated for aesthetic efficacy. Excellent results were observed in 94.8% of sites treated with nonfrozen BoNT/A and in 93.3% of the sites treated with frozen and thawed BoNT/A (p = 1). Minor side effects were rare and transient in both groups. In contrast to common belief, reconstituted BoNT/A may be frozen, thawed, and injected without losing its potency for up to 6 months, with efficacy equivalent to that of freshly prepared BoNT/A.